TTR and spinal muscular atrophy, type 1: The TTR up-regulation in the nuisinersen-treated SMA type 1 patients we investigated may indeed represent a nusinersen-dependent enhancement of the CNS positive reaction to neuronal damage for neuron survival and function restoring.